Squarepoint
SRTA

Squarepoint’s Strata Critical Medical Inc SRTA Stock Holding History

Squarepoint’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Buy
+115,324
New +$607K ﹤0.01% 3271
2026
Q1 		– Sell
-92,013
Closed -$443K – 4293
2025
Q4 		$443K Sell
92,013
-297,402
-76% -$1.44M ﹤0.01% 3310
2025
Q3 		$1.97M Buy
389,415
+307,621
+376% +$1.36M ﹤0.01% 2121
2025
Q2 		$330K Buy
81,794
+25,709
+46% +$83.7K ﹤0.01% 3613
2025
Q1 		$153K Buy
56,085
+11,780
+27% +$42.3K ﹤0.01% 4102
2024
Q4 		$188K Buy
44,305
+12,311
+38% +$46.9K ﹤0.01% 4493
2024
Q3 		$94.1K Buy
+31,994
New +$102K ﹤0.01% 3883
2024
Q1 		– Sell
-96,836
Closed -$342K – 4045
2023
Q4 		$342K Buy
96,836
+74,414
+332% +$214K ﹤0.01% 3269
2023
Q3 		$58.1K Buy
22,422
+734
+3% +$2.58K ﹤0.01% 3621
2023
Q2 		$85.5K Sell
21,688
-3,131
-13% -$9.93K ﹤0.01% 3386
2023
Q1 		$83.9K Buy
+24,819
New +$101K ﹤0.01% 3003
2022
Q2 		– Sell
-97,319
Closed -$826K – 2893
2022
Q1 		$826K Buy
+97,319
New +$684K ﹤0.01% 1702
2021
Q4 		– Sell
-13,713
Closed -$143K – 3170
2021
Q3 		$143K Buy
+13,713
New +$120K ﹤0.01% 2596

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's SRTA Position: Q2 2026 in Review

Squarepoint opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 115,324 shares worth $608K. The stake represents ﹤0.01% of the portfolio and ranks #3271 among its holdings. This is a return to the name: Squarepoint previously reported a position in SRTA as recently as Q4 2025.

Squarepoint first reported a position in SRTA in Q3 2021 and has held it in 13 quarters since. The position peaked at $1.97M in Q3 2025. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Squarepoint held 115,324 shares of Strata Critical Medical Inc worth $608K as of Q2 2026.
  • Strata Critical Medical Inc was a new Squarepoint position in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3271 holding.
  • Squarepoint first reported a position in Strata Critical Medical Inc in Q3 2021 and has held it in 13 quarters since.
  • Squarepoint's Strata Critical Medical Inc position peaked at $1.97M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.